This message was sent to ##Email##
|
|
|
|
|
| New approaches to desmoid tumors treatment featured in the Bulletin of the American College of Surgeons
|
    |
An article in this month’s issue of the Bulletin explores changing approaches to the management of desmoid tumors (DTs). Although aggressive, upfront surgical resection was historically recommended for all DTs, new approaches to treatment include active surveillance, radiation therapy, cryoablation and novel medical therapies, according to authors from the American College of Surgeons Clinical Research Program.
| 2020 CoC Surveys: What you need to know
|
|
As the calendar moves closer to year-end, the 2020 Commission on Cancer (CoC) survey year is fast approaching. For those programs anticipating surveys in the coming year, important updates regarding the Survey Application Record (SAR), surveyor assignments, fees and criteria are available on CoC Datalinks.
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
| CoC reviews database versus clinical research clarification for CoC standard
|
|
Last week, the CoC Program Review Subcommittee made a determination regarding whether databases that collect information without defined research purpose qualify for research accrual under Standard 1.9.
Because these databases collect information with no guarantee that it will be used in cancer research or lead to clinical scenarios that evaluate one form of care versus another, they do not qualify for accrual for CoC Standard 1.9. This clarification will go into effect January 1, 2020. This includes:
- Lung Cancer CT Database (ACR)
- National Mammography Database
- The Society of Thoracic Surgeons (STS) Registry on lung and esophageal resections
However, a clinical study that utilizes information from these databases through an Institutional Review Board (IRB) mechanism can be used for accruals in Standard 1.9.
| Join the NAPRC surveyor team
|
|
The National Accreditation Program for Rectal Cancer (NAPRC) is seeking physicians to join its accreditation surveyor team. Surveyors conduct on-site visits with rectal cancer programs seeking NAPRC accreditation to assist in verifying a program’s compliance with the NAPRC Standards.
Applicants must be actively practicing physicians specializing in rectal cancer care and working in a program that is NAPRC accredited or is actively working toward NAPRC accreditation. Please visit the NAPRC website for more information on qualifications and to download the application.
| |
SERVICE SHOWCASE | Advertisement
|
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
| HEALTH CARE NEWS AND UPDATES |
Medscape
For the first time, a guideline recommends that screening for colorectal cancer should not be routinely recommended for all adults aged 50 to 79 years, but instead should be limited to individuals with an elevated level of risk.
The new guideline, from an international panel of experts, goes against the grain. At present, many countries recommend routine screening for all older individuals, and recently some groups have even lowered the starting age to 45 years.
READ MORE
Cancer Network
Although frequency is on the rise, mortality rates due to thyroid cancer are declining because of earlier diagnosis. Nevertheless, mortality rates vary by thyroid cancer type. In a bid to seek out new therapeutic targets, Liu and co-investigators went on a hunt for biomarkers, detailing results in a study published in the Journal of Cellular Physiology.
READ MORE
|
Advertisement
|
|
|
|
|
Medical Xpress
A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London. The research was part-funded by Cancer Research UK and Breast Cancer Now.
READ MORE
Cancer Research UK
Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumor, according to a trio of papers published in Nature Medicine.
READ MORE
 |
|
VTI’s Remotely Operated Suction Irrigation System (or “ROSI”) presents a new paradigm in suction and irrigation for robot-assisted procedures. The ROSI system gives the console surgeon complete control of suction and irrigation capabilities.
|
|
EurekaAlert
A new, multicenter study led by Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center determined how a single mutation in splicing factor 3b subunit 1 (SF3B1), the most frequently mutated splicing factor gene, drives the formation of many cancers. The findings are published in the journal Nature.
READ MORE
ScienceDaily
An Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the "dark matter" of human cancer DNA.
The mutation, as described in two related studies published in Nature on October 9, 2019, represents a new potential therapeutic target for several types of cancer including brain, liver and blood cancer. This target could be used to develop novel treatments for patients with these difficult-to-treat diseases.
READ MORE
ScienceDaily
Patients with mesothelioma may gain similar benefit from immunotherapy as chemotherapy, and good responders may provide important clues to novel treatment for the thousands of new cases each year. New data highlight the need to understand the biological mechanisms whereby mesothelioma, which is incurable, adapts to immunotherapy in some patients but not in others, resulting in variations in treatment response.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
